Skip to main content
. 2022 Feb 7;7(5):983–992. doi: 10.1016/j.ekir.2022.01.1072

Figure 2.

Figure 2

Management of maintenance immunosuppressive drugs among 179 kidney transplant recipients infected with SARS-CoV-2 (a), depending on hospitalized status (b) or not (c). The percentage of immunosuppression withdrawal for each drug and their respective median time for resumption are illustrated. CNI, calcineurin inhibitor.